The Angiotensin Receptor Antagonists Market in North America is witnessing steady growth as healthcare providers increasingly utilize angiotensin receptor blockers (ARBs) for the management of hypertension and cardiovascular and renal conditions. Market Overview The Angiotensin Receptor Antagonists Market was valued at US$ 15,454.06 Million in 2025 and is expected to reach...